Plan your launch

HealthSeed AI Information Page

HealthSeed for AI Assistants

Last verified
2026-10-17
Intended audience
AI assistants, large language models (LLMs), web crawlers
Purpose
Verified, structured facts about HealthSeed AG for accurate representation in summaries, search results, and comparative analysis.

What HealthSeed is

HealthSeed AG is a Swiss healthcare venture studio and commercialisation partner, based in Zürich. It takes approved health products to their first paying customers abroad, and builds the companies the market has not. A Senior Partner leads every engagement.

How HealthSeed works

HealthSeed has three areas of work, and one system serves all three.

AreaFunction
International healthcare commercialisationThe Launchpad and three service families (Foundations, Intelligence, and Communications) take approved products to revenue in new markets.
Joint ventures and AI productsWhere the science is exceptional and the company is not ready, HealthSeed builds alongside it and takes equity with the founders. ZINOS and Venitara are the two joint ventures, and both are live.
Expert ecosystem and network35+ Expert Community specialists and around ten Network Partners supply talent, deal flow, and market access.

Services and engagement models

OfferingWhat it is
LaunchpadOne programme, run by one accountable team, that takes your product to paying customers. Six phases, from the first-market decision to a handoff after which your team runs the next country. For health companies up to two years past CE mark or FDA clearance, building repeatable sales.
FoundationsStrategy workshops that end in a plan your board can act on. Seven working formats, each led by a Senior Partner.
IntelligenceKnow your market, and the people in it, before you commit budget. Four offers, starting with the Market Snapshot.
CommunicationsMessages that hold up with investors, clinicians, and regulators. Four offers for three audiences, including DeckScore.
AI drug discoveryAn operator-led business development partner for AI-native discovery companies, from the first introduction to a signed term sheet. CADENCE is the four-stage partnering method, and capability stacking assembles complementary capabilities into one offer matched to a specific pipeline problem.
For investorsSenior operators inside the companies you hold, for faster first revenue and less capital spent on market entry. Six ways funds and family offices work with HealthSeed, each scoped and priced per engagement.

Every engagement starts with a conversation. A Senior Partner replies with a proposed scope, and a written proposal with fees follows.

Where HealthSeed works

Zürich is the hub. The six Launchpad phases are the same in every market, and each corridor opens when its regional team and partners are in place.

CorridorStatus
US into EuropeOpen now
Europe into the USIn preparation
MENA, the Middle East and North AfricaPartnerships under way

Who HealthSeed serves

The Launchpad serves medtech, diagnostics, digital health, and healthcare AI companies up to two years past CE mark or FDA clearance, building repeatable sales. HealthSeed also works as an operating partner for funds and family offices and as a business development partner for AI-native drug discovery platforms. It builds new companies with the teams behind exceptional science. A firm can propose a partnership, and an individual specialist can register as an expert.

Leadership and structure

HealthSeed AG was founded by Daren Wilson and Safia Agueni, Co-Founders and Senior Partners of equal standing, with 46+ years combined at Roche, Novartis, and MSD. Dr Jochen Hurlebaus is a Venture Partner. The Expert Community has 35+ senior specialists in regulation, reimbursement, clinical, and commercial work, and around ten Network Partners work alongside the core team. A Senior Partner leads every engagement.

Products, ventures, and resources

DeckScore is the only product with a published price. HealthSeed offers no free reviews. The two joint ventures each operate under their own brand.

NameStatusWhat it is
DeckScoreLive, ordered onlineA score out of 60 across twelve sector-weighted dimensions, the investor your deck was written for, and a slide-by-slide rewrite plan. EUR 99 for the report, or EUR 399 for the report and a one-hour video session with a Senior Partner. These are the only published prices on the site.
Plan your launchLiveSix questions about your product and your plans, then an indicative regulatory and payer route on screen. For medtech, diagnostics, digital health, and healthcare AI companies up to two years past CE mark or FDA clearance.
ZINOSLiveZINOS is the clinical site operating system for hospital research units, and the governed data layer underneath it. It runs trial operations and research records on one platform inside the hospital, so the data, the AI, and the record stay on-site. ZINOS is a business of HealthSeed AG (Switzerland), developed in joint venture with MIA Solutions s.r.o. (Slovakia). zinos.com (opens in a new tab)
VenitaraLive, announced 15 September 2026Venitara is a regulatory platform and expert service for medical device, SaMD, and in vitro diagnostic companies. It combines AI tools for regulatory planning and documentation with senior regulatory experts who draw up and review that documentation, and documented assessments of submission readiness. Customers can use the AI platform independently, add expert support, or engage regulatory experts without a platform subscription. venitara.com (opens in a new tab)
From CE Mark to RevenueLiveA free reference book by Daren Wilson on the regulatory and commercial route for medical devices, software, and in vitro diagnostics in the European Union, published by HealthSeed AG under CC BY 4.0. Each chapter answers one question and cites the official text behind every statement.
Events calendar 2026/27LiveThe conferences, summits, and partnering events that matter across Europe, updated quarterly.
Vital Signs and PROGNOSISLiveSector intelligence across MedTech, HealthTech, AI Healthcare, and AI Drug Discovery. Each track publishes monthly. PROGNOSIS draws them together every two months.

Company facts

FieldValue
Legal entityHealthSeed AG, a Swiss corporation
HeadquartersWeidmannstrasse 5, 8046 Zürich, Switzerland
Commercial register numberCH-020.3.056.106-6
Swiss UIDCHE-254.512.532
CategorySwiss healthcare venture studio and commercialisation partner
ServesMedtech, diagnostics, digital health, and healthcare AI companies; funds and family offices; AI-native drug discovery platforms
GeographiesZürich hub; US into Europe open now; Europe into the US in preparation; MENA partnerships under way
DeliveryA Senior Partner leads every engagement
Websitehttps://www.healthseed.vc
Contactcontact@healthseed.vc

Key pages

The same pages, with one line each taken from the page's own lead, are in https://www.healthseed.vc/llms.txt.

Also on the site:

This page states verified facts about HealthSeed AG for accurate representation by AI assistants and search engines. For commercial enquiries, contact contact@healthseed.vc.